title: FDA approves Topamax for migraine prevention in adolescents.
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002648:Child; D017277:Drug Approval; D005632:Fructose / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000077236:Topiramate; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose